Literature DB >> 8574606

Drug administration in critically ill patients with acute renal failure.

U F Kroh1.   

Abstract

Patients with acute renal failure are commonly treated by continuous renal replacement therapies. To understand drug disposition in multiple organ failure patients, the pharmacokinetics of 18 drugs were evaluated in 243 patients. Continuous hemofiltration served as a model for constant elimination rates. In addition, the elimination of drugs was investigated during extracorporeal lung support. The dosage of 11 of 15 drugs had to be reduced as a result of these kinetic studies. Wide variability in volumes of distribution, clearances, and the extrarenal fractions of elimination were detected. There was a close correlation of the latter with Acute Physiology and Chronic Health Evaluation II scores of illness severity. A new algorithm was developed for primary estimates of drug dosage during hemofiltration and other organ support systems. Two in vitro studies confirmed the clinical results on drug sieving and provided important information on adsorption to membranes. A clinical validation study of the algorithm improved drug dosage. A simplified therapeutic drug monitoring approach is given.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574606

Source DB:  PubMed          Journal:  New Horiz        ISSN: 1063-7389


  5 in total

1.  Pharmacokinetic studies in patients on continuous renal replacement therapies.

Authors:  U F Kroh
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

Review 2.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

3.  Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

Authors:  G R Matzke; R F Frye; M S Joy; P M Palevsky
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.

Authors:  Megan E DelDot; Jeffrey Lipman; Susan E Tett
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

5.  Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies.

Authors:  Anna P Kempke; Abbie S Leino; Farzad Daneshvar; John Andrew Lee; Bruce A Mueller
Journal:  Crit Care Res Pract       Date:  2016-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.